JOSEPH LENDVAY: Open Payments
NPI 1720027840 · LOYSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,556 in 125 payments from 21 companies in 2025. Trend: 2023 $2,314 · 2024 $2,177 · 2025 $2,556
Food & beverage: $2,556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $487 |
| Novo Nordisk Inc | 27 | $457 |
| AstraZeneca Pharmaceuticals LP | 10 | $290 |
| Phathom Pharmaceuticals, Inc. | 11 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $183 |
| Dexcom, Inc. | 5 | $168 |
| GlaxoSmithKline, LLC. | 10 | $157 |
| PFIZER INC. | 5 | $99 |
| Exact Sciences Corporation | 3 | $69 |
| Lilly USA, LLC | 4 | $67 |
Products named: VRAYLAR, Wegovy, VOQUEZNA, FARXIGA, JARDIANCE, Dexcom G6 Transmitter, QULIPTA, Rybelsus.
Industry payments across PA — which companies pay providers there.
